Impact of four antimutagens on apoptosis in genotoxically damaged lymphocytes in vitro.
An antimutagenic activity of fluphenazine, todralazine, anthocyanins and alkylresorcinols was established in a battery of short-term cytogenetic tests. One of the possible mechanisms of their antimutagenic action could be an increase in apoptotic elimination of heavily-damaged cells from a culture. In this paper we provide data on quantitative estimation of the antimutagens' impact on apoptosis in lymphocyte cultures exposed in the G(0)-phase to genotoxic agents: hydrogen peroxide (0.2mM, 20 min.) or benzo[a]pyrene (40 microM, 90 min.), and then cultured for 36 hrs in the presence of a lectin (PHA-M, 1% v/v) and each of the tested antimutagens. Apoptosis was estimated by means of microscopic examination of cell smears stained with a mixture of fluorochromes (ethidium bromide/acridine orange) as well as of the results of DNA separation with the field inversion gel electrophoresis. By microscopic examination we assessed that the frequencies of cells exhibiting morphological features of apoptosis considerably increased in the cultures containing the antimutagens. The FIGE separation of DNA from those cultures proved that the DNA content in the 30-50 kb domain was markedly elevated, as compared with the control cultures that did not contain antimutagens. It was established in the regression analysis that the apoptosis-enhancing effect significantly depended on the concentration of each tested antimutagen in a culture medium. However, marked differences of apoptosis-enhancing potency were noticed among the four antimutagens. The multicriterial analysis proved that the apoptosis-enhancing effects of fluphenazine and also, to a smaller extent, by alkylresorcinols, were many times stronger than those of anthocyanins and of todralazine. The results suggest that the enhancement of apoptosis by fluphenazine and by alkylresorcinols can explain a major part of their antimutagenic activity, whereas in the case of anthocyanins and of todralazine other mechanisms of antimutagenic action should be sought for.
Gasiorowski
K
K
Wroclaw Medical University, Department of Basic Medical Sciences, Kochanowskiego 14, 51- 601 Wrocław, Poland. kaz@basmed.am.wroc.pl
Brokos
B
B
Kulma
A
A
Ogorzałek
A
A
Skórkowska
K
K
D016587:Antimutagenic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects*; D001564:Benzo(a)pyrene / Q000494:pharmacology; D002478:Cells, Cultured; D004247:DNA / Q000032:analysis / Q000235:genetics; D004249:DNA Damage / Q000187:drug effects* / Q000235:genetics; D004587:Electrophoresis, Agar Gel; D006801:Humans; D006861:Hydrogen Peroxide / Q000494:pharmacology; D008214:Lymphocytes / Q000166:cytology* / Q000187:drug effects* / Q000378:metabolism; D008297:Male; D008856:Microscopy, Fluorescence; D008875:Middle Aged; D016296:Mutagenesis / Q000187:drug effects / Q000235:genetics; D009153:Mutagens / Q000494:pharmacology*; D009336:Necrosis; D016192:Resting Phase, Cell Cycle / Q000187:drug effects; D012854:Sister Chromatid Exchange / Q000187:drug effects / Q000235:genetics; D013194:Staining and Labeling
D016587:Antimutagenic Agents; D009153:Mutagens; D001564:Benzo(a)pyrene; D004247:DNA; D006861:Hydrogen Peroxide